Erythroderma is the term applied to any inflammatory skin disease affecting more than 90% of the body surface. The incidence of neonatal and infantile erythroderma was 0.11% in an Indian study. There are various causes of neonatal and infantile erythroderma such as congenital, metabolic, papulosquamous, eczematous, drug induced, infections, autoimmune diseases, and malignancy but it is quite difficult to establish the etiology in early stage of life due to less specific clinical, biochemical and histological findings as compared to adults. Proper history, examination, skin biopsy, and various other relevant investigations (based on the differential diagnoses) are imperative to the diagnosis of neonatal and infantile erythroderma. Ruling out immunodeficiency in a child with failure to thrive is important. Since erythroderma is a dermatological emergency, its wise management is mandatory. Vitals, input-output, serum electrolytes, etc., are to be precisely monitored. Barrier nursing is of utmost importance in such cases. Any complication is to be dealt with, and specific treatment of particular cause of childhood and infantile erythroderma is to be done.
Introduction
Erythroderma or exfoliative dermatitis is the term applied to any inflammatory skin disease affecting more than 90% of the body surface. [1] It is a reaction pattern of the skin manifested by erythema and scaling that can complicate many underlying skin conditions at any age. It is a less common entity in the pediatric patients. [2] The incidence of neonatal and infantile erythroderma was 0.11% in a study done by Sarkar et al. in Delhi. [3] In adults, erythroderma may be due to drugs or secondary to preexisting dermatoses, while in the neonatal period it can be the primary manifestation of several conditions such as immunodeficiency and ichthyosiform syndrome. [4] The etiology of neonatal and infantile erythroderma is difficult to find and is often delayed due to the less specific clinical, biochemical and histological signs. Moreover, the causes of erythoderma in this age group are quite distinctive. [5] It is imperative for dermatologists as well as pediatricians to recognize erythroderma, its consequences and differentiate it from benign erythemas of childhood, and to prevent its mismanagement.
Classification
It can be classified based on the following: 1. Duration of disease
• Acute (few days) • Chronic. 2. Age of onset [6] • 3. Vesicles/bullae formation [6] • [4, 5, [7] [8] [9] [10] [11] • 
Etiology
In a retrospective study done in France by Pruszkowski et al., on 51 cases of erythroderma in neonates and infants, excluding those with blistering, the various underlying causes were: immunodeficiency -30%, ichthyosis (simple and complex) -24%, Netherton syndrome -18%, eczematous and papulosquamous dermatitis -20%, and erythroderma of unknown etiology-10% [12] Table 1 shows causes of childhood erythroderma in studies done in India.
Pathogenesis
The pathogenesis of erythroderma appears complex. It develops secondary to an intricate interaction of cytokines and cellular adhesion molecules like interleukin 1, 2, intercellular adhesion molecule, and the tumor necrosis factor (TNF). These interactions result in a florid increase in the epidermal cell turnover rate and accelerated mitosis resulting in excessive scaling and erythema. [15] [16] [17] [18] It manifests as a excessive loss of epidermal material along with protein, iron, and folate. [17] In addition to these basic changes, all above mentioned diseases have their own specific pathogenesis.
Approach

1.
History [4, 5, [7] [8] [9] [10] [11] 19] • [4, 5, [7] [8] [9] [10] [11] 19] • Skin biopsy -It is essential, and as in adults, it is advisable to take 2-3 specimens simultaneously from different sites. Findings are mentioned in Flow Chart 1.
• 
Treatment
General measures
Temperature, pulse, respiratory rate, blood pressure, and input-output need to be strictly monitored. Electrolyte, metabolic acidosis is to be looked for and managed carefully. Adequate application of bland emollients, wet dressings are helpful in decreasing scaling and fissuring. 0.01% potassium permanganate soaks are used over erosions for its astringent, antibacterial, and antifungal effects. Severe complications such as septicemic infections, hypoalbuminemia, hyperpyrexia, hypernatremic dehydration, and cardiac failure should be managed timely. [4, 5, [7] [8] [9] [10] [11] 19] 
Specific measures
Treatment of underlying diseases such as antibiotics, antifungals, and antiscabicidal for bacterial infections, candidiasis, and scabies, respectively. Atopic dermatitis and drug-induced erythroderma may need a short course of oral corticosteroids. Drug-induced cases also require withdrawal of offending drug. Psoriasis, ichthyosis may need oral retinoids while immunosuppressants are required for the management of dermatomyositis, pemphigus foliaceus, and sarcoidosis. Immunodeficiencies are treated with bone marrow transplantation. [4, 5, [7] [8] [9] [10] [11] 19] 
Recent Advances
• Oral liarozole, a retinoic acid metabolism-blocking agent, an alternative to systemic retinoid therapy, can be given in patients with lamellar ichthyosis [20] • Water-in-oil emulsion of 10% N-acetyl cysteine in combination with 5% urea topically for lamellar ichthyosis, epidermolytic ichthyosis which can present as erythroderma [21, 22] 
Flow Chart 2: Brief outline of approach to a neonate/infant with erythroderma
There is a need of multidisciplinary approach for the management of such patients by dermatologists and pediatricians.
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